FDA announces landmark approval of gene therapy for inherited retinal dystrophies
- Posted on: Dec 19 2017
- Leave a response
A suite of formerly untreatable, progressively blinding retinal diseases may now be halted or even reversed, thanks to FDA approval of the gene therapy agent, Luxturna. The announcement marks the first U.S. approval of a gene therapy for an inherited disease.
Source: AAO
Posted in: Uncategorized
